Showing results (221-230 of 474) with videos related to

Sort By:
Pageof 48
Urology|April 18, 2001
Tamoxifen and colchicine-modulated vinblastine followed by 5-fluorouracil in advanced renal cell carcinoma: a phase II studyJ H Liu, M H Yang, F S Fan, et al.
Urologia Internationalis|January 1, 1997
Is renal function at the tumor side a prognostic factor in ureteral transitional cell carcinoma?H J Chung, K K Chen, A T Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1981
Marfan syndrome: abnormal alpha 2 chain in type I collagenP H Byers, R C Siegel, K E Peterson, et al.
Journal of Korean Medical Science|July 15, 2000
Abnormalities of erythrocyte membrane proteins in Korean patients with hereditary spherocytosisY K Lee, H I Cho, S S Park, et al.
Cancer Immunology Research|June 6, 2024
CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor ActivityNaveen K Mehta, Kavya Rakhra, Kristan A Meetze, et al.
Journal of Neuroscience Research|September 6, 2000
Functional ionotropic glutamate receptors emerge during terminal cell division and early neuronal differentiation of rat neuroepithelial cellsD Maric, Q Y Liu, G M Grant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2026
GLP-1 receptor agonist use and cancer risk in obese nondiabetic adultsA H-C Hsu, P T Ramirez, Y-H Chang, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 22, 2017
Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for GlaucomaRona Chandrawati, Jason Y H Chang, Ester Reina-Torres, et al.
AJNR. American Journal of Neuroradiology|April 7, 2018
Edge Contrast of the FLAIR Hyperintense Region Predicts Survival in Patients with High-Grade Gliomas following Treatment with BevacizumabN Bahrami, D Piccioni, R Karunamuni, et al.
American Journal of Epidemiology|April 1, 1996
Ethnic differences in immune responses to hepatitis B vaccineL C Hsu, S R Lin, H M Hsu, et al.
Pageof 48